Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

NCT05630313 · clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

Collaborators